News - UF Innovate

‘More Hopeful Outcomes’ on the Horizon for Prader-Willi Syndrome

Prader-Willi syndrome, a neurodevelopmental disorder that occurs in about 1 in 15,000 births, is the most common genetic cause of life-threatening childhood obesity, which is...

An Interest in Bat Viruses Led to UF Health Virologist’s Development of Coronavirus Test

The UF College of Public Health and Health Professions’ department of environmental and global health and the UF Emerging Pathogens Institute, are leading a joint,...

UF Professor Receives 2020 American Academy of Sleep Medicine Award

Several leaders in the field of sleep medicine and two members of Congress are recipients of the 2020 American Academy of Sleep Medicine awards. Dr....

Sinclair, Altavian Partner to Use 3-D Technology to Print Masks

UF startup Altavian, a drone maker that supplies the US military, and Sinclair College, a Dayton, Ohio-based community college, have partnered to rapidly produce and...

Oragenics, Inc. Announces Early Top-Line Results of Phase 2 Clinical Trial of AG013 for Oral Mucositis in Chemoradiation Treatment of Head and Neck Cancer

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and...

COVID-19 and Food Safety: Fact and Fiction for Food Production

Consumers are being bombarded with tips for what to do with their groceries during the coronavirus crisis. Leave them in the garage for three days? Wash...

The Big Picture: EPI’s Director Speaks About the Covid-19 Pandemic

The Emerging Pathogens Institute was formed in 2006 to bring researchers across disciplines together with the goal of better understanding and anticipating new disease-causing microorganisms...

DiaCarta Gets FDA Emergency Use Authorization for Coronavirus PCR Test

UF Innovate | Sid Martin Biotech alum DiaCarta, a molecular diagnostic firm, has obtained the Emergency Use Authorization from the US Food and Drug Administration...

Full Interview: Algernon Pharmaceuticals Announces Regulatory Submission for COVID-19 Trial in South Korea

Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive Vancouver to discuss another development for their repurposed...

TAO Connect Opens Mental Health Resources to the Public at No Cost to Assist With the Effects of COVID-19

UF startup and UF Innovate | The Hub graduate TAO Connect, a digital platform designed to make behavioral health therapy more accessible and effective, announced...

UF News